Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...